HUMA - Humacyte, Inc.
1.19
-0.020 -1.681%
Share volume: 2,021,776
Last Updated: 05-09-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$1.21
-0.02
-0.02%
Summary score
20%
Profitability
0%
Dept financing
24%
Liquidity
46%
Performance
32%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 30-Sep-2020 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.66%
Return on assets
-17.41%
Return on sales
-28850.6%
Return on invested capital
-42.05%
Total debt ratio
74.66%
Debt ratio change over timeo
-2.19%
Current Ratio
9.52%
Quick Ratio
11.8%
Cash Position Ratio
9.3%
Short-term ratios 30-Sep-2023 - 30-Sep-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-30.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
119.93%
Debt ratio change over timeo
0%
Current Ratio
4.96%
Quick Ratio
0%
Cash Position Ratio
4.82%
Last quarter ratios 30-Sep-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-32.83%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
155.52%
Debt ratio change over time
0%
Current Ratio
1.1%
Quick Ratio
0%
Cash Position Ratio
0.98%
Performance ratios (change over 4 years) 30-Sep-2020 - 30-Sep-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-36.45%
Return on assets
-73.92%
Return on sales
-41958.21%
Return on invested capital
93.31%
Total debt ratio
-218.85%
Debt ratio change over time
-2.19%
Current Ratio
-19.45%
Quick Ratio
-19.45%
Cash Position Ratio
-19.07%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HUMA | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -16.66% | 18.34% | 6.69% | 16.49% |
| Return on assets | -17.41% | 3.17% | 3.1% | 15.3% |
| Return on sales | -28850.6% | 30.73% | 28.93% | 7.81% |
| Return on invested capital | -42.05% | 5.33% | 3.55% | -56.8% |
| Profitability | 0% | 80% | 54% | 54% |
| Total debt ratio | 74.66% | 91.7% | 67.67% | 20.78% |
| Debt ratio change over time | -2.19% | 20.48% | 127.93% | -1.07% |
| Dept financing | 20% | 29% | 43% | 6% |
| Current Ratio | 4.96% | 1.41% | 1.23% | 10.4% |
| Quick Ratio | 0% | 0.99% | 1.06% | 10.21% |
| Cash Position Ratio | 4.82% | 0.49% | 0.42% | 5.61% |
| Liquididy | 75% | 10% | 7% | 43% |
| Short-term ratios | HUMA | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 6.26% | 0.37% |
| Return on assets | -30.73% | 2.14% | 0.55% | 0.13% |
| Return on sales | 0% | 18.91% | 3.35% | -117.21% |
| Return on invested capital | 0% | 0% | 4.11% | 10% |
| Profitability | 0% | 50% | 46% | 28% |
| Total debt ratio | 119.93% | 93.35% | 66.02% | 11.14% |
| Debt ratio change over time | 0% | 0% | 12.37% | -0.23% |
| Dept financing | 25% | 19% | 39% | 2% |
| Current Ratio | 4.96% | 1.41% | 1.23% | 10.4% |
| Quick Ratio | 0% | 0.99% | 1.06% | 10.21% |
| Cash Position Ratio | 4.82% | 0.49% | 0.42% | 5.61% |
| Liquididy | 33% | 8% | 7% | 75% |
